FDA Drug Recalls Explained

Why Drug Recalls Happen

Drug recalls can be alarming, but they are a sign that the safety monitoring system is working. The FDA tracks drug quality through inspections, adverse event reports, and manufacturer self-reporting. When a problem is identified, contamination, incorrect dosage, mislabeling, manufacturing defects, the affected products are pulled from distribution.

The most common causes of recalls are manufacturing defects (contamination, incorrect potency, particulate matter), labeling errors (wrong dosage listed, missing warnings), and quality failures at manufacturing facilities. Less commonly, new safety information discovered after approval can trigger market withdrawals. PlainMeds tracks active recalls from FDA Enforcement Reports so you can check your medications.

Understanding Recall Classifications

The FDA classifies recalls into three levels based on potential health risk:

What it tells you: Class I is the FDA's most serious tier (reasonable probability of serious harm or death). Class II is the volume leader in this catalogue (temporary or medically reversible problems). Class III is the least severe definition and, in these Enforcement Reports, the smallest action count.

What it doesn't tell you: The recall class is the FDA's assessment of potential risk, not the actual harm that has occurred. A Class I recall might be issued preventively before any adverse events are reported. The absence of a recall does not prove a drug is free of quality issues; the FDA relies heavily on manufacturer self-reporting.

How this registry uses it: PlainMeds lists the FDA class next to each Enforcement Report row on the drug profile. The class is not medical advice about whether to stop a medicine. See methodology.

How an Enforcement Report is listed here

FDA recall announcements name specific lot numbers. PlainMeds copies the Enforcement Report class, reason, and date onto the matching drug profile when that product is in the catalogue. The agency database is FDA Recalls, Market Withdrawals & Safety Alerts. A recall usually names lots, not every package of the drug.

Adverse-event reports go to the FDA MedWatch program. Those reports are a separate FAERS stream from recall actions.

Frequently Asked Questions

Recall Classification Comparison Table

Classification	Health Risk Level	Example Trigger	Share of this catalogue
Class I	Serious harm or death	NDMA contamination in ranitidine	103 (9%)
Class II	Temporary or reversible harm	Dissolution test failure (wrong release rate)	997 (85%)
Class III	Unlikely to cause harm	Label typo, packaging defect	79 (7%)

Worked example: the 2018-2019 valsartan NDMA wave

In 2018-2019, FDA Enforcement Reports listed valsartan lots from multiple manufacturers after NDMA, a probable human carcinogen, was found in the active ingredient. Not every manufacturer or lot was named. PlainMeds shows the class, reason, and date on the valsartan profile when those rows are in the catalogue. The class on those rows is the agency risk grade for the named lots, not a verdict about every valsartan tablet.

What are the three classes of FDA drug recalls?

Class I: serious health consequences or death possible. Class II: temporary or reversible problems. Class III: unlikely to cause adverse consequences. In this catalogue Class II leads by count; Class III has the fewest actions.

Where does PlainMeds list FDA recall actions?

Drug profiles list Enforcement Report rows with class, reason, and date. The FDA database is at fda.gov. A recall usually names lots, not every package.

What does an FDA recall class measure?

The class is the FDA risk grade for named lots, not a count of harm and not advice about stopping a medicine. Class I is the seriousness board; Class II is most of the action count here.

Why do generic names appear often in recall counts?

Generics fill most U.S. prescriptions, so they appear in more enforcement actions. Manufacturing is concentrated, so one facility problem can list many products.